| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | Republic of Korea | 2 | |
| #6 | WIPO (World Intellectual Property Organization) | 2 | |
| #7 | China | 1 | |
| #8 | Hong Kong | 1 | |
| #9 | Israel | 1 | |
| #10 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Greenberg Kenneth P | 19 |
| #2 | Lau Anthony | 11 |
| #3 | Makinson Stefanie | 11 |
| #4 | Finer Mitchell H | 9 |
| #5 | David Nathaniel | 5 |
| #6 | Keifer Orion | 5 |
| #7 | Keifer Orion Jr | 3 |
| #8 | Keifer Jr Orion | 3 |
| #9 | David Nathaniel E | 1 |
| #10 | Glorioso Iii Joseph C | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021035179A1 | Compositions and methods for neurological diseases | |
| KR20200112811A | Composition and method for neurodegenerative diseases | |
| EP3374494A1 | Crispr compositions and methods of using the same for gene therapy | |
| AU2016324317A1 | Compositions and methods for treating neurological disorders | |
| US2018148711A1 | Genome editing vectors |